TWINSTRAND BIOSCIENCES INC.

In News

Del. Judge Won't Touch Jury's $83M Diagnostics IP Verdict - Law360

Law360 - Jun 16, 2026

Guardant Fails to Undo $83 Million DNA-Tech Patent Verdict (1) - Bloomberg Law News

Bloomberg Law News - Jun 17, 2026

TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology - PR Newswire

PR Newswire - Jul 31, 2024

Guardant Can Try Again To Nix Patent Tied To $83M Verdict - Law360

Law360 - Jan 23, 2026

Guardant Health hit with $83M verdict in TwinStrand DNA sequencing patent lawsuit - Fierce Biotech

Fierce Biotech - Nov 15, 2023

Federal Jury Finds Guardant Health Willfully Infringes University of Washington Duplex Sequencing Patents Exclusively Licensed to TwinStrand Biosciences, Inc., Awards $83.4M in Damages; PTAB Rejects Invalidity Arguments on UW Patents - PR Newswire

PR Newswire - Nov 15, 2023

Guardant Health owes $83.4 mln in DNA sequencing patent case, US jury says - Reuters

Reuters - Nov 15, 2023

Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML) - FNIH

FNIH - Jun 06, 2023

Natera strengthens IP position with Archerdx win - BioWorld News

BioWorld News - Dec 04, 2023

Novo Nordisk laying off 86 workers as part of lab shutdown in Seattle - GeekWire

GeekWire - Mar 01, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment